News

R1 RCM (NASDAQ:RCM) ticked higher after the European antitrust regulator approved Towerbrook and CD&R's planned $14.30 a share purchase. The European Commission approved the combination under a ...
R1 RCM (NASDAQ:RCM) agreed to be sold to TowerBrook and Clayton, Dubilier & Rice in a deal valued at $8.9 billion. R1 RCM ...